Retatrutide

6 articles in Retatrutide

Pharmacokinetics & Absorption

Retatrutide Pharmacokinetics and Tissue Distribution

Eli Lilly's 2023 Phase 2 trial data revealed how retatrutide's pharmacokinetics—specifically its absorption and extended half-life enabled by a fatty acid modification—allow weekly dosing despite targeting three hormone receptors simultaneously.

AdminUpdated Aug 139 min

Glucagon Receptor Signaling

Glucagon Receptor Agonist Metabolic Effects

In 1923, Canadian researchers identified glucagon as insulin's metabolic counterpart—a pancreatic hormone that raised blood sugar. A century later, glucagon receptor agonist research reveals the hormone's effects extend far beyond glucose regulation, influencing lipid metabolism, hepatic physiology,

AdminUpdated Aug 1210 min

Retatrutide

Retatrutide Side Effects and Safety Profile Explained

Retatrutide's impressive weight loss results have sparked excitement, but understanding its safety profile and potential long-term side effects is crucial for clinicians and patients alike as research continues.

AdminUpdated Jul 2811 min

Retatrutide

Retatrutide vs Semaglutide vs Tirzepatide: Which Is Best?

Explore the latest in obesity treatment with our retatrutide vs semaglutide vs tirzepatide comparison, revealing which weight loss peptide stands out in this competitive and promising field.

AdminUpdated Jul 2813 min

Retatrutide

Retatrutide Mechanism of Action Explained

Discover the retatrutide mechanism of action explained: this groundbreaking triple agonist targets GLP-1, GIP, and glucagon receptors simultaneously, offering a novel approach to weight loss and metabolic regulation unlike anything before.

AdminUpdated Jul 2817 min

Retatrutide

What Is Retatrutide? The Triple-Agonist Peptide (GLP-1, GIP & Glucagon), Explained

Curious about the groundbreaking triple-agonist peptide? Discover what is retatrutide—the innovative GLP-1, GIP, and glucagon receptor activator shaping the future of metabolic health.

AdminUpdated Jul 2812 min